An original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapy

Abstract Aneuploidy is a hallmark of cancers, but the role of aneuploidy-related genes in lung adenocarcinoma (LUAD) and their prognostic value remain elusive. Gene expression and copy number variation (CNV) data were enrolled from TCGA and GEO database. Consistency clustering analysis was performed...

Full description

Bibliographic Details
Main Authors: Yalei Zhang, Dongmei Li
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-58020-y
_version_ 1797219904828473344
author Yalei Zhang
Dongmei Li
author_facet Yalei Zhang
Dongmei Li
author_sort Yalei Zhang
collection DOAJ
description Abstract Aneuploidy is a hallmark of cancers, but the role of aneuploidy-related genes in lung adenocarcinoma (LUAD) and their prognostic value remain elusive. Gene expression and copy number variation (CNV) data were enrolled from TCGA and GEO database. Consistency clustering analysis was performed for molecular cluster. Tumor microenvironment was assessed by the xCell and ESTIMATE algorithm. Limma package was used for selecting differentially expressed genes (DEGs). LASSO and stepwise multivariate Cox regression analysis were used to establish an aneuploidy-related riskscore (ARS) signature. GDSC database was conducted to predict drug sensitivity. A nomogram was designed by rms R package. TCGA-LUAD patients were stratified into 3 clusters based on CNV data. The C1 cluster displayed the optimal survival advantage and highest inflammatory infiltration. Based on integrated intersecting DEGs, we constructed a 6-gene ARS model, which showed effective prediction for patient’s survival. Drug sensitivity test predicted possible sensitive drugs in two risk groups. Additionally, the nomogram exhibited great predictive clinical treatment benefits. We established a 6-gene aneuploidy-related signature that could effectively predict the survival and therapy for LUAD patients. Additionally, the ARS model and nomogram could offer guidance for the preoperative estimation and postoperative therapy of LUAD.
first_indexed 2024-04-24T12:41:04Z
format Article
id doaj.art-fa7f5792ea7f4b0e835c1f66f6a03823
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-24T12:41:04Z
publishDate 2024-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-fa7f5792ea7f4b0e835c1f66f6a038232024-04-07T11:16:24ZengNature PortfolioScientific Reports2045-23222024-04-0114111410.1038/s41598-024-58020-yAn original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapyYalei Zhang0Dongmei Li1Department of Thoracic Oncology, The First Affiliated Hospital of Guangzhou Medical UniversityDepartment of Thoracic Oncology, The First Affiliated Hospital of Guangzhou Medical UniversityAbstract Aneuploidy is a hallmark of cancers, but the role of aneuploidy-related genes in lung adenocarcinoma (LUAD) and their prognostic value remain elusive. Gene expression and copy number variation (CNV) data were enrolled from TCGA and GEO database. Consistency clustering analysis was performed for molecular cluster. Tumor microenvironment was assessed by the xCell and ESTIMATE algorithm. Limma package was used for selecting differentially expressed genes (DEGs). LASSO and stepwise multivariate Cox regression analysis were used to establish an aneuploidy-related riskscore (ARS) signature. GDSC database was conducted to predict drug sensitivity. A nomogram was designed by rms R package. TCGA-LUAD patients were stratified into 3 clusters based on CNV data. The C1 cluster displayed the optimal survival advantage and highest inflammatory infiltration. Based on integrated intersecting DEGs, we constructed a 6-gene ARS model, which showed effective prediction for patient’s survival. Drug sensitivity test predicted possible sensitive drugs in two risk groups. Additionally, the nomogram exhibited great predictive clinical treatment benefits. We established a 6-gene aneuploidy-related signature that could effectively predict the survival and therapy for LUAD patients. Additionally, the ARS model and nomogram could offer guidance for the preoperative estimation and postoperative therapy of LUAD.https://doi.org/10.1038/s41598-024-58020-yLung adenocarcinomaAneuploidyRiskscore modelNomogramTherapy
spellingShingle Yalei Zhang
Dongmei Li
An original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapy
Scientific Reports
Lung adenocarcinoma
Aneuploidy
Riskscore model
Nomogram
Therapy
title An original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapy
title_full An original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapy
title_fullStr An original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapy
title_full_unstemmed An original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapy
title_short An original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapy
title_sort original aneuploidy related gene model for predicting lung adenocarcinoma survival and guiding therapy
topic Lung adenocarcinoma
Aneuploidy
Riskscore model
Nomogram
Therapy
url https://doi.org/10.1038/s41598-024-58020-y
work_keys_str_mv AT yaleizhang anoriginalaneuploidyrelatedgenemodelforpredictinglungadenocarcinomasurvivalandguidingtherapy
AT dongmeili anoriginalaneuploidyrelatedgenemodelforpredictinglungadenocarcinomasurvivalandguidingtherapy
AT yaleizhang originalaneuploidyrelatedgenemodelforpredictinglungadenocarcinomasurvivalandguidingtherapy
AT dongmeili originalaneuploidyrelatedgenemodelforpredictinglungadenocarcinomasurvivalandguidingtherapy